{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:23:53Z","timestamp":1774513433228,"version":"3.50.1"},"reference-count":29,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.3892\/etm.2015.2694","type":"journal-article","created":{"date-parts":[[2015,8,20]],"date-time":"2015-08-20T10:18:43Z","timestamp":1440065923000},"page":"1419-1422","source":"Crossref","is-referenced-by-count":21,"title":["Anti-mitochondrial M2 antibody-positive autoimmune hepatitis"],"prefix":"10.3892","volume":"10","author":[{"given":"MINORU","family":"TOMIZAWA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FUMINOBU","family":"SHINOZAKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAZUNORI","family":"FUGO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YASUFUMI","family":"MOTOYOSHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKAO","family":"SUGIYAMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHIGENORI","family":"YAMAMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKASHI","family":"KISHIMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NAOKI","family":"ISHIGE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,8,20]]},"reference":[{"key":"key20180108124056_b1-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2012.11.002","article-title":"Autoimmune hepatitis: A comprehensive review","volume":"41","author":"Liberal","year":"2013","journal-title":"J Autoimmun"},{"key":"key20180108124056_b2-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2013.08.001","article-title":"Clinical significance of autoantibodies in autoimmune hepatitis","volume":"46","author":"Liberal","year":"2013","journal-title":"J Autoimmun"},{"key":"key20180108124056_b3-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"key":"key20180108124056_b4-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1872-034X.2012.01105.x","article-title":"Intractable Hepato-Biliary Diseases Study Group Of Japan: Etiology and prognosis of fulminant hepatitis and late-onset hepatic failure in Japan: Summary of the annual nationwide survey between 2004 and 2009","volume":"43","author":"Oketani","year":"2013","journal-title":"Hepatol Res"},{"key":"key20180108124056_b5-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10620-012-2445-4","article-title":"Acute and acute severe (fulminant) autoimmune hepatitis","volume":"58","author":"Czaja","year":"2013","journal-title":"Dig Dis Sci"},{"key":"key20180108124056_b6-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/j.1572-0241.2008.01922.x","article-title":"Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis","volume":"103","author":"Montano","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"key20180108124056_b7-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/hep.25658","article-title":"Long-term outcome of Japanese patients with type 1 autoimmune hepatitis","volume":"56","author":"Yoshizawa","year":"2012","journal-title":"Hepatology"},{"key":"key20180108124056_b8-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.autrev.2014.01.041","article-title":"The diagnosis of primary biliary cirrhosis","volume":"13","author":"Bowlus","year":"2014","journal-title":"Autoimmun Rev"},{"key":"key20180108124056_b9-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.humpath.2012.09.017","article-title":"Evaluation of a new histologic staging and grading system for primary biliary cirrhosis in comparison with classical systems","volume":"44","author":"Kakuda","year":"2013","journal-title":"Hum Pathol"},{"key":"key20180108124056_b10-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"American Association For The Study Of Liver Diseases: Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"key20180108124056_b11-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2036.2005.02403.x","article-title":"Diagnosis and treatment of autoimmune hepatitis at age 65 and older","volume":"21","author":"Verslype","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"key20180108124056_b12-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.clinre.2013.05.002","article-title":"Autoantibodies in primary biliary cirrhosis: Antimitochondrial autoantibodies","volume":"37","author":"Chantran","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"key20180108124056_b13-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"American Association For Study Of Liver Diseases: Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"key20180108124056_b14-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","article-title":"Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis","volume":"138","author":"Gershwin","year":"1987","journal-title":"J Immunol"},{"key":"key20180108124056_b15-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/0016-5085(93)90656-W","article-title":"The nature and prognosis of severe cryptogenic chronic active hepatitis","volume":"104","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"key20180108124056_b16-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/hep.510230307","article-title":"Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex","volume":"23","author":"Moteki","year":"1996","journal-title":"Hepatology"},{"key":"key20180108124056_b17-etm-0-0-2694","first-page":"47","article-title":"Molecular biology of the 2-oxo-acid dehydrogenase complexes and anti-mitochondrial antibodies","volume":"10","author":"Gershwin","year":"1992","journal-title":"Prog Liver Dis"},{"key":"key20180108124056_b18-etm-0-0-2694","first-page":"505","article-title":"Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope","volume":"22","author":"Leung","year":"1995","journal-title":"Hepatology"},{"key":"key20180108124056_b19-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3748\/wjg.v20.i10.2606","article-title":"Autoantibodies in primary biliary cirrhosis: Recent progress in research on the pathogenetic and clinical significance","volume":"20","author":"Yamagiwa","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key20180108124056_b20-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s005350300006","article-title":"A scoring system for primary biliary cirrhosis and its application for variant forms of autoimmune liver disease","volume":"38","author":"Yamamoto","year":"2003","journal-title":"J Gastroenterol"},{"key":"key20180108124056_b21-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1440-1746.2006.04130.x","article-title":"Applicability of the IAIHG scoring system to the diagnosis of antimitochondrial\/anti-M2 seropositive variant form of autoimmune hepatitis","volume":"21","author":"Farias","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"key20180108124056_b22-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24481","article-title":"The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury","volume":"54","author":"Suzuki","year":"2011","journal-title":"Hepatology"},{"key":"key20180108124056_b23-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: Review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"key20180108124056_b24-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy","volume":"28","author":"Chazouilleres","year":"1998","journal-title":"Hepatology"},{"key":"key20180108124056_b25-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s12072-012-9413-0","article-title":"Humoral autoimmune response heterogeneity in the spectrum of primary biliary cirrhosis","volume":"7","author":"Dellavance","year":"2012","journal-title":"Hepatol Int"},{"key":"key20180108124056_b26-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1386-6346(99)00079-0","article-title":"Analysis of two major anti-M2 antibodies (anti-PDC-E2\/anti-BCOADC-E2) in primary biliary cirrhosis: Relationship to titers of immunofluorescent anti-mitochondrial antibody","volume":"18","author":"Miyakawa","year":"2000","journal-title":"Hepatol Res"},{"key":"key20180108124056_b27-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1386-6346(03)00014-7","article-title":"Immunoreactivity to pyruvate dehydrogenase complex-E2 in well-defined patients with autoimmune hepatitis: Western blot analysis","volume":"26","author":"Yanagawa","year":"2003","journal-title":"Hepatol Res"},{"key":"key20180108124056_b28-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s002160051569","article-title":"Bio- and chemiluminescence in bioanalysis","volume":"366","author":"Roda","year":"2000","journal-title":"Fresenius J Anal Chem"},{"key":"key20180108124056_b29-etm-0-0-2694","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","article-title":"Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis","volume":"48","author":"O'Brien","year":"2008","journal-title":"Hepatology"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2015.2694\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T08:39:53Z","timestamp":1691915993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2015.2694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,20]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,8,20]]},"published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.3892\/etm.2015.2694"],"URL":"https:\/\/doi.org\/10.3892\/etm.2015.2694","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,20]]}}}